SNHG17 has emerged as an oncogene in several cancer types, including colorectal cancer, hepatocellular carcinoma, gastric cancer, and breast cancer, as it exhibits increased expression levels in these tumor types [22–25]. The gene discussed is SNHG17; the disease is gastric cancer.